PCN71 COST-EFFECTIVENESS (CE) ANALYSIS OF ERBB2-TARGETED THERAPIES IN WOMEN WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ METASTATIC BREAST CANCER (MBC) AND LIMITED EXPOSURE TO PRIOR CHEMOTHERAPY (CT)

✍ Scribed by T Delea; O Sofrygin; P Tappenden; D Browning; MM Amonkar; J Karnon; K Lykopoulos

• Book ID: 118610906
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 91 KB
• Volume: 12
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)73308-8